Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

Ann Oncol. 2019 Jan 1;30(1):150-151. doi: 10.1093/annonc/mdy469.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary
  • Diarrhea / chemically induced
  • Diarrhea / drug therapy*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Prognosis
  • Protein Kinase Inhibitors / adverse effects*

Substances

  • Anti-Bacterial Agents
  • Protein Kinase Inhibitors